Search Results - "Montazeri, Kamaneh"

ABCDE steps to prevent heart disease in breast cancer survivors by Montazeri, Kamaneh, Unitt, Christine, Foody, JoAnne M, Harris, Jay R, Partridge, Ann H, Moslehi, Javid

Get full text

1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial by Patel, Sapna P, Carvajal, Richard, Montazeri, Kamaneh, Reddy, Sunil, Lutzky, Jose, Khan, Shaheer A, Chmielowski, Bartosz, Bhatia, Shailender, Medina, Theresa, Haymaker, Cara, Sheth, Rahul, Kuban, Joshua D, Thornton, Lindsay, Wehrenberg-Klee, Eric, Novelli, Paula, Lucci, Anthony, Sarli, Vanessa, Meas, Salyna, Cox, Bryan, LaPorte, Jason, Guha, Prajna, Ghosh, Chandra C, Hulstine, Ann-Marie, Knight, Robert, Moody, Ashley, Geller, David, Katz, Steven, Orloff, Marlana, Davar, Diwakar

“…BackgroundMUM-LM are resistant to ICIs for several reasons including the prevalence of myeloid-derived suppressor cells (MDSCs). PFS has been limited, even…”
Get full text

Erdafitinib for the treatment of metastatic bladder cancer by Montazeri, Kamaneh, Bellmunt, Joaquim

“…: Since the approval of immune checkpoint inhibitors (ICIs), there has been continuing and significant progress in urothelial cancer (UC) treatment. However,…”
Get more information

Salvage systemic therapy for metastatic urothelial carcinoma: an unmet clinical need by Montazeri, Kamaneh, Sonpavde, Guru

“…Metastatic urothelial carcinoma (mUC) remains a fatal malignancy, despite the recent addition of immune check point inhibitors (ICIs), an FGFR inhibitor and an…”
Get full text

Case 2-2024: A 57-Year-Old Woman with Melanoma and Fever by Mohareb, Amir M., Kang, Jiyoon, Montazeri, Kamaneh, Shroff, Stuti G.

“…A 57-year-old woman with resected stage IIIC melanoma was admitted because of fever and hypotension. Treatment with BRAF–MEK inhibitors had been started 4…”
Get full text

Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis by Wang, Mike, Reynolds, Kerry L., Montazeri, Kamaneh, Schaefer, Esperance A., Sullivan, Ryan J., Dougan, Michael

“…Immune checkpoint inhibitors (ICI) have improved metastatic melanoma outcomes; however, toxicities, such as hepatitis, can be dose-limiting or even fatal.1…”
Get full text

Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations by Montazeri, Kamaneh, Pattanayak, Vikram, Sullivan, Ryan J

“…Uveal melanoma (UM) is a rare type of melanoma with distinct features from cutaneous melanoma, low response rates to immune checkpoint inhibition, and poor…”
Get full text

Breast Cancer Chemotherapy and Your Heart by Unitt, Christine, Montazeri, Kamaneh, Tolaney, Sara, Moslehi, Javid

Get full text

Safety and early biologic effects of phase 1 PERIO-01 trial of pressure-enabled drug delivery (PEDD) of TLR9 agonist SD-101 and immune checkpoint inhibition (ICI) in uveal melanoma metastatic to the liver (MUM) by Montazeri, Kamaneh, Davar, Diwakar, Haymaker, Cara L., Sheth, Rahul, Kuban, Joshua, Weintraub, Joshua, Wehrenberg-Klee, Eric, Novelli, Paula M., Gonsalves, Carin F., Adamo, Robert D., Lucci, Anthony, Meas, Salyna, Sarli, Vanessa Nicole, Prieto, Victor Gerardo, Geller, David A., Orloff, Marlana M., Carvajal, Richard D., Patel, Sapna Pradyuman

“…2521 Background: Delivery barriers due to intratumoral pressure and immunosuppression related to myeloid-derived suppressor cells (MDSC) in liver tumors have…”
Get full text

Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023 by Seedor, Rino S, Aplin, Andrew E, Bertolotto, Corine, Carvajal, Richard D, Deacon, Nigel, Doble, Katie, Hamid, Omid, Haq, Rizwan, Kadosh, Miriam, Khan, Shaheer, Kraska, Jacqueline, Lutzky, Jose, McKean, Meredith, Montazeri, Kamaneh, Moser, Justin, Onken, Michael, Orloff, Marlana, Sacco, Joseph J, Smalley, Keiran, Selig, Sara M

“…The 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting was held in Philadelphia on November 6, 2023. There is increased awareness and dedicated…”
Get full text

Resource utilization and cost efficacy analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC) by Montazeri, Kamaneh, Dranitsaris, George, Curran, Catherine, Thomas, Jonathan David, Ingham, Matthew D., Preston, Mark A., Steele, Graeme S., Kilbridge, Kerry L., Wei, Xiao X., McGregor, Bradley Alexander, Mossanen, Matthew, Sonpavde, Guru

“…Abstract only e19390 Background: DD-MVAC and GC are commonly used NAC regimens for MIBC. While efficacy across studies appears similar, resource utilization…”
Get full text

Resource utilization analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC) by Montazeri, Kamaneh, Dranitsaris, George, Curran, Catherine, Thomas, Jonathan David, Ingham, Matthew D., Preston, Mark A., Steele, Graeme S., Kilbridge, Kerry L., Wei, Xiao X., McGregor, Bradley Alexander, Mossanen, Matthew, Sonpavde, Guru

“…Abstract only 474 Background: DD-MVAC and GC are commonly used NAC regimens for MIBC. While efficacy across studies appears similar, the resource utilization…”
Get full text

Abstract P3-14-03: A phase 1b study of the CDK4/6 inhibitor ribociclib in combination with the PD-1 inhibitor spartalizumab in patients with hormone receptor-positive metastatic breast cancer (HR+ MBC) and metastatic ovarian cancer (MOC) by Herold, Christina I, Trippa, Lorenzo, Li, Tianyu, Do, Khanh, Bardia, Aditya, Anderson, Leilani, Montazeri, Kamaneh, Pittenger, Jessica, Andrews, Chelsea, Mittendorf, Elizabeth A, Goel, Shom, Winer, Eric P, Shapiro, Geoffrey I, Tolaney, Sara M

“…Abstract Background: Immune checkpoint inhibitors (ICI), such as those targeting the PD-1/PD-L1 axis, have shown modest activity as monotherapy in both HR+ MBC…”
Get full text

Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma by Sato, Takuto, Montazeri, Kamaneh, Gragoudas, Evangelos S, Lane, Anne Marie, Aronow, Mary Beth, Cohen, Justine V, Boland, Genevieve M, Banks, Eric, Kachulis, Christopher, Fleharty, Mark, Cibulskis, Carrie, Lawless, Aleigha, Adalsteinsson, Viktor A, Sullivan, Ryan J, Kim, Ivana K

“…Somatic chromosomal alterations, particularly monosomy 3 and 8q gains, have been associated with metastatic risk in uveal melanoma (UM). Whole genome-scale…”
Get more information

Urinalysis in acute care of adults: pitfalls in testing and interpreting results by Pallin, Daniel J, Ronan, Clare, Montazeri, Kamaneh, Wai, Katherine, Gold, Allen, Parmar, Siddharth, Schuur, Jeremiah D

“…Rapid urine tests for infection (urinalysis, dipstick) have low up-front costs. However, many false positives occur, with important downstream consequences,…”
Get full text

Abstract 5881: PERIO-01: Initial safety experience and immunologic effects of a Class C TLR9 agonist using pressure- enabled drug delivery in a phase 1 trial of hepatic arterial infusion of SD-101 +/- checkpoint inhibition in metastatic uveal melanoma by Patel, Sapna P., Haymaker, Cara, Sheth, Rahul A., Kuban, Joshua D., Weintraub, Joshua, Wehrenberg-Klee, Eric, Novelli, Paula, Gonsalves, Carin, Adamo, Robert, Honaker, Virgina, Timciuc, Laura, Hennegan, Tarin, Molina, Juan C. Amador, Duose, Dzifa, Cuenta, Edwin R. Parras, Lucci, Anthony, Meas, Salyna, Sarli, Vanessa, Prieto, Victor G., LaPorte, Jason, Hulstine, Ann-Marie, Moody, Ashley, Cox, Bryan, Geller, David, Davar, Diwakar, Montazeri, Kamaneh, Orloff, Marlana, Katz, Steven C., Carvajal, Richard

“…Abstract Immune checkpoint inhibitors (ICI) have demonstrated limited success in patients with metastatic uveal melanoma (MUM) with liver involvement due to an…”
Get full text

Cardiology patient page. Breast cancer chemotherapy and your heart by Unitt, Christine, Montazeri, Kamaneh, Tolaney, Sara, Moslehi, Javid

Get full text